16th Wallace H. Clark JR., MD Lectureship in Cutaneous Oncology and Melanoma Symposium CME

Arthur Rubenstein Auditorium Smilow Center for Translational Research
3400 Civic Center Blvd
Philadelphia, PA 19104

This symposium is designed to update participants on important topics in melanoma and related pigmented lesions of the skin. Penn Medicine faculty will provide updates on issues critical to the management of melanoma patients.

Online registration CLOSED but walk-ins are welcome.

View Agenda  

Target Audience

The target audience is dermatologists, medical oncologists, hematologists/oncologists, surgical oncologists, radiation oncologists, primary care physicians, oncology nurses, and other healthcare professionals who care for patients with melanoma.

Learning Objectives

At the completion of this course, participants should be able to:

• Describe clinical pathways for melanoma treatment
• Identify advances in surgical management of melanoma
• Discuss new therapeutic options for malignant melanoma
• Describe the optimal sequencing for immunotherapy management

Accreditation

In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Designation Of Credit

• PHYSICIANS: Penn Medicine designates this live activity for a maximum of 2.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
• PHYSICIAN ASSISTANTS:  AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 2.5 Category 1 credits for completing this activity.

Disclosures

Penn Medicine, Office of Continuing Medical and Interprofessional Education, adheres to the ACCME Standards for Commercial Support. Faculty and planner’s disclosure information will be made available in the conference materials and syllabus. Faculty members are also expected to disclose to participants any discussion of off-label and / or investigational use of pharmaceutical products or devices within their presentations.

Agenda

• 11:15 am — Registration & Lunch
• 12:15 pm — Welcome & Introduction
  Rosalie Elenitsas, MD
• 12:20 pm — Penn Pathways for Melanoma
  Christopher J. Miller, MD
• 12:45 pm — Recent Advances in Melanoma Surgery
  Giorgos C. Karakousis, MD
• 1:15 pm — Panel Debate:Should This Patient Have a Sentinel Lymph Node Biopsy?
  • Moderator: Rosalie Elenitsas, MD
  • Panel: Christopher J. Miller, MD, Giorgos C. Karakousis, MD and Lynn M. Schuchter, MD
• 1:40 pm — Panel Q&A
  • Moderator: Rosalie Elenitsas, MD
  • Panel: Giorgos C. Karakousis, MD, John N. Lukens, MD, Christopher J. Miller, MD, Tara C. Mitchell, MD and  Lynn M. Schuchter, MD
• 2:00 pm — Break
• 2:15 pm — Clark Lectureship: Adjuvant Therapy for Melanoma: Head-spinning Progress
   Lynn M. Schuchter, MD
• 3:00 pm — Close of Conference